Published in Pediatr Nephrol on January 20, 2013
Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol (2014) 1.79
Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria. Kidney Int (2014) 1.42
Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria. J Am Soc Nephrol (2015) 1.18
Acute and chronic kidney injury in nephrolithiasis. Curr Opin Nephrol Hypertens (2014) 0.99
Novel diuretic targets. Am J Physiol Renal Physiol (2013) 0.93
Do kidney stone formers have a kidney disease? Kidney Int (2015) 0.90
Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol (2016) 0.88
Update on cystinuria. Curr Opin Nephrol Hypertens (2013) 0.85
Nephrolithiasis, kidney failure and bone disorders in Dent disease patients with and without CLCN5 mutations. Springerplus (2015) 0.83
Oxalate quantification in hemodialysate to assess dialysis adequacy for primary hyperoxaluria. Am J Nephrol (2014) 0.80
Kidney Disease in Adenine Phosphoribosyltransferase Deficiency. Am J Kidney Dis (2015) 0.80
Impact of nephrolithiasis on kidney function. BMC Nephrol (2015) 0.78
Adenine phosphoribosyltransferase deficiency as a rare cause of renal allograft dysfunction. J Am Soc Nephrol (2014) 0.78
Primary hyperoxaluria type 1 in 18 children: genotyping and outcome. Int J Nephrol (2015) 0.77
Recent advances in managing and understanding nephrolithiasis/nephrocalcinosis. F1000Res (2016) 0.77
Loss of function of NaPiIIa causes nephrocalcinosis and possibly kidney insufficiency. Pediatr Nephrol (2016) 0.76
The search for monogenic causes of kidney stones. J Am Soc Nephrol (2014) 0.76
Adenine phosphoribosyltransferase deficiency in the United Kingdom: two novel mutations and a cross-sectional survey. Clin Kidney J (2016) 0.75
Rare case of nephrocalcinosis in a 14-year-old girl: Answers. Pediatr Nephrol (2016) 0.75
Pediatric Kidney Stones - Avoidance and Treatment. Curr Treat Options Pediatr (2016) 0.75
Rationale and Design of the Registry for Stones of the Kidney and Ureter (ReSKU): A Prospective Observational Registry to Study the Natural History of Urolithiasis Patients. J Endourol (2016) 0.75
Stones: The dark side of stone disease - stones do still kill. Nat Rev Urol (2016) 0.75
Mutations in SLC26A1 Cause Nephrolithiasis. Am J Hum Genet (2016) 0.75
The Clinical Impact of Accurate Cystine Calculi Characterization Using Dual-Energy Computed Tomography. Case Rep Radiol (2015) 0.75
Probiotics for prevention of urinary stones. Ann Transl Med (2017) 0.75
Targeting gene expression to specific cells of kidney tubules in vivo, using adenoviral promoter fragments. PLoS One (2017) 0.75
An unusual cause of "pink diaper" in an infant: Answers. Pediatr Nephrol (2015) 0.75
Urinary Stone Disease: Advancing Knowledge, Patient Care, and Population Health. Clin J Am Soc Nephrol (2016) 0.75
The exposome for kidney stones. Urolithiasis (2015) 0.75
Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria. Can J Kidney Health Dis (2015) 0.75
Dent disease in Poland: what we have learned so far? Int Urol Nephrol (2017) 0.75
Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease. Clin Biochem (2017) 0.75
Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int (2003) 9.11
Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science (1999) 6.04
Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins. Nature (2005) 3.60
Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. Nature (2005) 3.58
Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet (2006) 2.96
ClC-5 Cl- -channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature (2000) 2.79
Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. J Am Soc Nephrol (2002) 2.59
The primary hyperoxalurias. Kidney Int (2009) 2.53
Comparative anatomy of the human APRT gene and enzyme: nucleotide sequence divergence and conservation of a nonrandom CpG dinucleotide arrangement. Proc Natl Acad Sci U S A (1987) 2.49
ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells. Proc Natl Acad Sci U S A (1998) 2.34
Mutations in DHDPSL are responsible for primary hyperoxaluria type III. Am J Hum Genet (2010) 2.32
Urolithiasis in pediatric patients. Mayo Clin Proc (1993) 2.28
Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex. J Clin Invest (2008) 2.24
High citrate diet delays progression of renal insufficiency in the ClC-5 knockout mouse model of Dent's disease. Kidney Int (2005) 2.02
Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome. Kidney Int (2009) 2.01
Paracellin-1 and the modulation of ion selectivity of tight junctions. J Cell Sci (2005) 1.90
Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis. Hum Mol Genet (2000) 1.87
Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules. Proc Natl Acad Sci U S A (2003) 1.87
Dent Disease with mutations in OCRL1. Am J Hum Genet (2004) 1.81
Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis. Clin J Am Soc Nephrol (2011) 1.79
Mutational analysis demonstrates that ClC-4 and ClC-5 directly mediate plasma membrane currents. J Biol Chem (1999) 1.78
Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol (2001) 1.73
Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout. Arthritis Rheum (2005) 1.70
Clinical features and genotype of adenine phosphoribosyltransferase deficiency in iceland. Am J Kidney Dis (2001) 1.68
Molecular etiology of primary hyperoxaluria type 1: new directions for treatment. Am J Nephrol (2005) 1.66
Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int (2006) 1.65
Transgenic RNAi depletion of claudin-16 and the renal handling of magnesium. J Biol Chem (2007) 1.64
Endosomal chloride-proton exchange rather than chloride conductance is crucial for renal endocytosis. Science (2010) 1.62
Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium. Proc Natl Acad Sci U S A (2009) 1.60
Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure. Nephrol Dial Transplant (2010) 1.57
Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network. Mol Biol Cell (2005) 1.52
A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr Nephrol (2003) 1.50
Primary hyperoxaluria type 1: still challenging! Pediatr Nephrol (2006) 1.50
International registry for primary hyperoxaluria. Am J Nephrol (2005) 1.49
Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele. Kidney Int (2005) 1.48
Transplantation outcomes in primary hyperoxaluria. Am J Transplant (2010) 1.45
Diagnosis of adenine phosphoribosyltransferase deficiency as the underlying cause of renal failure in a renal transplant recipient. Nephrol Dial Transplant (2004) 1.45
Impaired acidification in early endosomes of ClC-5 deficient proximal tubule. Biochem Biophys Res Commun (2005) 1.44
Pathophysiology and treatment of cystinuria. Nat Rev Nephrol (2010) 1.40
Urinary phosphate/creatinine, calcium/creatinine, and magnesium/creatinine ratios in a healthy pediatric population. J Pediatr (1997) 1.40
Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int (1995) 1.40
Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis. J Am Soc Nephrol (2007) 1.39
Adenine phosphoribosyltransferase deficiency: a previously undescribed genetic defect in man. J Clin Invest (1968) 1.38
Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent's disease. Hum Mol Genet (1999) 1.38
Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med (1994) 1.36
CLDN16 genotype predicts renal decline in familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol (2007) 1.35
Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol (2011) 1.34
Disease-associated mutations affect intracellular traffic and paracellular Mg2+ transport function of Claudin-16. J Clin Invest (2006) 1.33
beta 2-Microglobulin instability in pathological urine. Clin Chem (1982) 1.31
Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int (2001) 1.31
Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency. J Am Soc Nephrol (2010) 1.30
Diagnostic examination of the child with urolithiasis or nephrocalcinosis. Pediatr Nephrol (2008) 1.30
Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Nephrol Dial Transplant (2011) 1.29
Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome. Nephrol Dial Transplant (2003) 1.28
Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders. Hum Mol Genet (1997) 1.27
Hypocalcemia and osteopathy in mice with kidney-specific megalin gene defect. FASEB J (2002) 1.26
Dent's disease. Orphanet J Rare Dis (2010) 1.23
Clinical use of cystine supersaturation measurements. J Urol (2000) 1.22
Hypomagnesaemia of hereditary renal origin. Pediatr Nephrol (1987) 1.21
Evidence for genetic heterogeneity in Dent's disease. Kidney Int (2004) 1.21
Implications of genotype and enzyme phenotype in pyridoxine response of patients with type I primary hyperoxaluria. Am J Nephrol (2005) 1.20
Nucleotide sequence of the human APRT gene. Nucleic Acids Res (1987) 1.20
Medical treatment of cystinuria: results of contemporary clinical practice. J Urol (1996) 1.18
Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1. Kidney Int (2006) 1.18
Dent's disease: clinical features and molecular basis. Pediatr Nephrol (2010) 1.16
Hypothesis: Dent disease is an underrecognized cause of focal glomerulosclerosis. Clin J Am Soc Nephrol (2007) 1.16
Dent's disease manifesting as focal glomerulosclerosis: Is it the tip of the iceberg? Pediatr Nephrol (2009) 1.15
From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. Hum Mutat (2011) 1.14
Adenine phosphoribosyltransferase deficiency and renal allograft dysfunction. Am J Kidney Dis (2001) 1.14
Management of primary hyperoxaluria: efficacy of oral citrate administration. Pediatr Nephrol (1993) 1.11
rBAT-b(0,+)AT heterodimer is the main apical reabsorption system for cystine in the kidney. Am J Physiol Renal Physiol (2002) 1.11
The variation of urinary oxalate excretion with age. J Lab Clin Med (1969) 1.09
Dent-2 disease: a mild variant of Lowe syndrome. J Pediatr (2009) 1.09
Urinary cystine excretion and capacity in patients with cystinuria. Kidney Int (2006) 1.07
The primary hyperoxalurias: an algorithm for diagnosis. Am J Nephrol (2005) 1.06
The impact of cystinuria on renal function. J Urol (2002) 1.06
Genetic causes of hypercalciuric nephrolithiasis. Pediatr Nephrol (2008) 1.06
Endocytosis of calcium oxalate crystals and proliferation of renal tubular epithelial cells in a patient with type 1 primary hyperoxaluria. J Urol (1992) 1.05
Pathogenesis of Dent's disease and related syndromes of X-linked nephrolithiasis. Kidney Int (2000) 1.04
One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience. Transplantation (2003) 1.04
Structural basis for ion conduction and gating in ClC chloride channels. FEBS Lett (2004) 1.01
Structural and biochemical studies of human 4-hydroxy-2-oxoglutarate aldolase: implications for hydroxyproline metabolism in primary hyperoxaluria. PLoS One (2011) 1.00
ClC-5: a chloride channel with multiple roles in renal tubular albumin uptake. Int J Biochem Cell Biol (2005) 0.99
Characterization of carrier females and affected males with X-linked recessive nephrolithiasis. J Am Soc Nephrol (1995) 0.99
An update on the changing epidemiology and metabolic risk factors in pediatric kidney stone disease. Clin J Am Soc Nephrol (2011) 0.98
Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria. J Endourol (2005) 0.97
Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis. BJU Int (2006) 0.97
Oxalate dynamics in chronic renal failure. Comparison with normal subjects and patients with primary hyperoxaluria. Nephron (1987) 0.96
Intra-familial clinical heterogeneity: absence of genotype-phenotype correlation in primary hyperoxaluria type 1 in Israel. Am J Nephrol (2005) 0.95
Only three mutations account for almost all defective alleles causing adenine phosphoribosyltransferase deficiency in Japanese patients. J Clin Invest (1992) 0.95
Adenine phosphoribosyltransferase deficiency in children. Pediatr Nephrol (2012) 0.95
The ClC-5 knockout mouse model of Dent's disease has renal hypercalciuria and increased bone turnover. J Bone Miner Res (2003) 0.94
The effect of dietary protein on cystine excretion in patients with cystinuria. Clin Nephrol (1984) 0.94
Renal failure due to 2,8-dihydroxyadenine urolithiasis. Eur J Pediatr (1982) 0.93
Urinary oxalate and glycolate excretion and plasma oxalate concentration. Arch Dis Child (1991) 0.92
From tonus to tonicity: physiology of CLC chloride channels. J Am Soc Nephrol (2000) 0.92
Urinary oxalate excretion by very low birth weight infants receiving parenteral nutrition. Pediatrics (1989) 0.90
Child's urinary lithiasis revealing a complete deficit in adenine phosphoribosyl transferase. Pediatr Res (1976) 0.89
Claudins in renal physiology and disease. Pediatr Nephrol (2011) 0.89
The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet (2002) 4.54
Minimal nuclear pore complexes define FG repeat domains essential for transport. Nat Cell Biol (2004) 3.30
Current issues in measurement and reporting of urinary albumin excretion. Clin Chem (2008) 2.98
Noninvasive differentiation of uric acid versus non-uric acid kidney stones using dual-energy CT. Acad Radiol (2007) 2.80
Prevalence of contraindications and prescription of pharmacologic therapies for gout. Am J Med (2011) 2.57
The primary hyperoxalurias. Kidney Int (2009) 2.53
Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation. Kidney Int (2010) 2.51
Piecemeal microautophagy of nucleus in Saccharomyces cerevisiae. Mol Biol Cell (2003) 2.48
Relative performance of the MDRD and CKD-EPI equations for estimating glomerular filtration rate among patients with varied clinical presentations. Clin J Am Soc Nephrol (2011) 2.47
KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. Am J Kidney Dis (2013) 2.43
For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int (2009) 2.32
Mutations in DHDPSL are responsible for primary hyperoxaluria type III. Am J Hum Genet (2010) 2.32
Shock wave lithotripsy and diabetes mellitus: a population-based cohort study. Urology (2011) 2.26
Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol (2009) 2.22
Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates. Transplantation (2013) 2.10
Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. J Appl Physiol (1985) (2006) 2.09
Comparison of aneroid and oscillometric blood pressure measurements in children. J Clin Hypertens (Greenwich) (2013) 2.02
Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat Dis (2005) 2.02
A novel assay for replicative lifespan in Saccharomyces cerevisiae. FEMS Yeast Res (2004) 1.93
Prevalence of renal artery and kidney abnormalities by computed tomography among healthy adults. Clin J Am Soc Nephrol (2010) 1.91
Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant (2011) 1.87
Phenotypic characterization of kidney stone formers by endoscopic and histological quantification of intrarenal calcification. Kidney Int (2013) 1.84
Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis. Clin J Am Soc Nephrol (2011) 1.79
High incidence of kidney stones in Icelandic children. Pediatr Nephrol (2005) 1.77
Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis. Am J Kidney Dis (2008) 1.77
Medullary sponge kidney: state of the art. Nephrol Dial Transplant (2012) 1.76
Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet (2009) 1.73
Urinalysis is more specific and urinary neutrophil gelatinase-associated lipocalin is more sensitive for early detection of acute kidney injury. Nephrol Dial Transplant (2012) 1.71
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int (2013) 1.69
Use of a probiotic to decrease enteric hyperoxaluria. Kidney Int (2005) 1.68
Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease. Kidney Int (2013) 1.66
Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery. Surgery (2011) 1.64
Cystinuria. Semin Nephrol (2008) 1.60
Characteristics of renal cystic and solid lesions based on contrast-enhanced computed tomography of potential kidney donors. Am J Kidney Dis (2012) 1.59
Temporal trends in incidence of kidney stones among children: a 25-year population based study. J Urol (2012) 1.59
Temporal trends in the incidence of kidney stone disease. Kidney Int (2012) 1.59
Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study. Crit Care (2014) 1.57
Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure. Nephrol Dial Transplant (2010) 1.57
Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases. PLoS Genet (2010) 1.57
Use of hemodialysis and hemoperfusion in poisoned patients. Kidney Int (2008) 1.56
Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves. Am J Physiol Heart Circ Physiol (2004) 1.55
Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia. Kidney Int (2008) 1.54
Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity. Kidney Int (2012) 1.52
Feasibility of discriminating uric acid from non-uric acid renal stones using consecutive spatially registered low- and high-energy scans obtained on a conventional CT scanner. AJR Am J Roentgenol (2015) 1.51
International registry for primary hyperoxaluria. Am J Nephrol (2005) 1.49
Urinary oxalate excretion increases in home parenteral nutrition patients on a higher intravenous ascorbic acid dose. JPEN J Parenter Enteral Nutr (2004) 1.49
Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele. Kidney Int (2005) 1.48
State of the art for measurement of urine albumin: comparison of routine measurement procedures to isotope dilution tandem mass spectrometry. Clin Chem (2013) 1.47
Performance of flow cytometry to screen urine for bacteria and white blood cells prior to urine culture. Clin Biochem (2013) 1.47
Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence. Transplantation (2009) 1.47
Glyoxylate reductase activity in blood mononuclear cells and the diagnosis of primary hyperoxaluria type 2. Nephrol Dial Transplant (2006) 1.44
Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol (2003) 1.44
Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol (2010) 1.44
Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation. Kidney Int (2008) 1.43
Cystone® for 1 year did not change urine chemistry or decrease stone burden in cystine stone formers. Urol Res (2010) 1.42
Health-related quality of life (HRQoL) in cystine compared with non-cystine stone formers. Urolithiasis (2013) 1.41
Dual-energy dual-source CT with additional spectral filtration can improve the differentiation of non-uric acid renal stones: an ex vivo phantom study. AJR Am J Roentgenol (2011) 1.41
Pathophysiology and treatment of cystinuria. Nat Rev Nephrol (2010) 1.40
Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis. J Am Soc Nephrol (2007) 1.39
Automated urinalysis in the clinical lab. MLO Med Lab Obs (2012) 1.39
Do high levels of n-3 polyunsaturated fatty acids in cell membranes increase the risk of postoperative atrial fibrillation? Cardiology (2013) 1.39
The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens (2008) 1.37
Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol (2011) 1.34
Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults. Nephrol Dial Transplant (2005) 1.33
Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota. Am J Kidney Dis (2009) 1.32
Cell biology of pathologic renal calcification: contribution of crystal transcytosis, cell-mediated calcification, and nanoparticles. J Investig Med (2006) 1.29
Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II. Kidney Int (2002) 1.25
The nucleoporins Nup170p and Nup157p are essential for nuclear pore complex assembly. J Cell Biol (2009) 1.24
Binding dynamics of structural nucleoporins govern nuclear pore complex permeability and may mediate channel gating. Mol Cell Biol (2003) 1.24
Timing and outcome of renal replacement therapy in patients with congenital malformations of the kidney and urinary tract. Clin J Am Soc Nephrol (2012) 1.24
Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy. J Clin Endocrinol Metab (2012) 1.23
Progressive renal papillary calcification and ureteral stone formation in mice deficient for Tamm-Horsfall protein. Am J Physiol Renal Physiol (2010) 1.22
Diagnosis of medullary sponge kidney by computed tomographic urography. Am J Kidney Dis (2007) 1.21
Increasing prevalence of kidney stones in the United States. Kidney Int (2003) 1.21
Implications of genotype and enzyme phenotype in pyridoxine response of patients with type I primary hyperoxaluria. Am J Nephrol (2005) 1.20
The role of continuous renal replacement therapy in the treatment of poisoning. Semin Dial (2006) 1.19
Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both. Am J Physiol Renal Physiol (2007) 1.18
Evolution of the metazoan-specific importin alpha gene family. J Mol Evol (2009) 1.16
Association of kidney function and metabolic risk factors with density of glomeruli on renal biopsy samples from living donors. Mayo Clin Proc (2011) 1.15
Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol (2012) 1.15
Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery? Europace (2010) 1.15
Surgical decompression is associated with decreased mortality in patients with sepsis and ureteral calculi. J Urol (2012) 1.14
Nucleus-vacuole junctions and piecemeal microautophagy of the nucleus in S. cerevisiae. Autophagy (2007) 1.13
Drosophila melanogaster importin alpha1 and alpha3 can replace importin alpha2 during spermatogenesis but not oogenesis. Genetics (2002) 1.10
Annexin II is present on renal epithelial cells and binds calcium oxalate monohydrate crystals. J Am Soc Nephrol (2003) 1.09
Oral antibiotic treatment of Helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes. J Endourol (2011) 1.09
Human-derived nanoparticles and vascular response to injury in rabbit carotid arteries: proof of principle. Int J Nanomedicine (2008) 1.08
Ichthyotoxic ARF after fish gallbladder ingestion: a large case series from Vietnam. Am J Kidney Dis (2003) 1.07
Monosodium urate stones are rare, and urine pH is not low in cystinuria. Am J Kidney Dis (2013) 1.07
Phenotypic and genetic heterogeneity in Dent's disease--the results of an Italian collaborative study. Nephrol Dial Transplant (2006) 1.07
TGFbeta1 induces epithelial-mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture. Int J Exp Pathol (2006) 1.06
Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study. Am J Kidney Dis (2009) 1.06
Nvj1p is the outer-nuclear-membrane receptor for oxysterol-binding protein homolog Osh1p in Saccharomyces cerevisiae. J Cell Sci (2004) 1.04
Interleukin-8 and CXCR1 receptor functional polymorphisms and susceptibility to acute pyelonephritis. J Urol (2007) 1.04
The absence of rhabdomyolysis-induced renal failure following the World Trade Center collapse. Am J Med (2002) 1.04
Dialysis initiation: what's the rush? Semin Dial (2013) 1.03